Abstract:Background This article aims to present research pertaining to the effect of angiotensin receptor-neprilysin double blocker on blocking the inflammatory mechanism mediated by NLRP3 inflammasome on hypertensive nephropathy. ARNI has not only been found to improve cardiac function but is also associated with a reduction in progressive deterioration of kidney function owing to hypertension by exerting anti-inflammation, anti-autophagy, anti-fibrosis and anti-Golgi’s apparatus. We hypothesized that administration of ARNI is more effective than valsartan alone in slowing progression of hypertensive renal disease. Methods Rat models with spontaneous hypertension were randomized into a no treatment group, valsartan group (60 mg/kg), ARNI group (70 mg/kg) or ARNI + A779 group (70 mg/kg + 400ng/kg) daily by gavage. Sprague-Dawley rats were subjected to the control conditions (without hypertension and treatment). The kidney tissue analyses were performed after 12 weeks. We detected the expression levels of NLRP3 and casepase-1 in kidney tissue, and NLRP3 levels in human embryonic kidney cells which were induced by ang II as hypertension cell model by Real-Time Polymerase Chain Reaction. To analyze the impact of ARNI on autophagy, we performed western blot analysis on renal tubules to measure the protein expression of NLRP3 inflammasome, and to measure the protein expression of P62 and LC3. Masson 3 staining method was used to stain renal fibrosis. Immunohistochemistry was performed to determine the expression sites of NLRP3. The Golgi apparatus in morphology of renal tubular cells was determined by transmission electron microscope. Results The untreated hypertensive renal disease rats exhibited tubular and glomerular damage, downregulation of pro-inflammatory, pro-autophagy, pro-fibrotic and pro-Golgi’s apparatus pathways. ARNI administration improved renal function and histology changes and attenuated most of the molecular markers of inflammation, autophagy, fibrosis and Golgi’s apparatus. Conclusions ARNI activation attenuates renal complications of arterial hypertension by reduction of kidney inflammation through selective actions requiring the renal tubular epithelium but not the glomerular endothelial cells and the circumferential mesangial interposition cell Angiotensin Receptor. ARNI was more effective than valsartan therapy alone in delaying the progression of hypertensive renal disease.

Antihypertensive power of Naringenin is mediated via attenuation of mineralocorticoid receptor (MCR)/ angiotensin converting enzyme (ACE)/ kidney injury molecule (Kim-1) signaling pathway

Naringenin Inhibits N-G-nitro-L-arginine Methyl Ester-Induced Hypertensive Left Ventricular Hypertrophy by Decreasing Angiotensin-Converting Enzyme 1 Expression

Naringenin'S Effects On Diuresis And Prevention Of Urolithiasis In Hypertensive Rats

Naringenin Attenuates Pressure Overload-Induced Cardiac Hypertrophy.

Comparative Analysis of the Protective Effect of Naringenin on Cardiovascular Parameters of Normotensive and Hypertensive Rats Subjected to the Myocardial Infarction Model

Naringenin Reduces Early Brain Injury in Subarachnoid Hemorrhage (SAH) Mice: the Role of the AMPK/SIRT3 Signaling Pathway

Notoginsenoside R 1 Reduces Blood Pressure in Spontaneously Hypertensive Rats Through a Long Non-Coding RNA AK 094457

Protective effect of novel angiotensin receptor neprilysin inhibitor S086 on target organ injury in spontaneously hypertensive rats

Protective Effects of Naringenin in a Rat Model of Sepsis-Triggered Acute Kidney Injury Via Activation of Antioxidant Enzymes and Reduction in Urinary Angiotensinogen

PROTECTIVE EFFECT OF NQO-1 MODULATOR QUERCETIN IN HYPERTENSIVE RATS

Renoprotective Effects of Antroquinonol in Rats with Nω-Nitro-l-Arginine Methyl Ester-Induced Hypertension

Hepatoprotective and Neuroprotective Effects of Naringenin against Lead-Induced Oxidative Stress, Inflammation, and Apoptosis in Rats

Angiotensin Receptor Neprilysin Inhibition mediates Renal Protection by ARNI (Sacubatril Valsartan) in Rats with Spontaneous Hypertension

Hypertensive Rats Treated Chronically With Nω-Nitro-L-Arginine Methyl Ester (L-NAME) Induced Disorder of Hepatic Fatty Acid Metabolism and Intestinal Pathophysiology

Hypertension Induced by Nitric Oxide Synthase Inhibitor Increases Responsiveness of Ventricular Myocardium and Aorta of Rat Tissue to Adrenomedullin Stimulation in Vitro.

Protective effect of the natural flavonoid naringenin in mouse models of retinal injury

Naringenin Attenuates Isoprenaline-Induced Cardiac Hypertrophy by Suppressing Oxidative Stress through the AMPK/NOX2/MAPK Signaling Pathway

Naringenin prevents doxorubicin-induced toxicity in kidney tissues by regulating the oxidative and inflammatory insult in Wistar rats

The ameliorative effect of Naringenin on fenamiphos induced hepatotoxicity and nephrotoxicity in a rat model: Oxidative stress, inflammatory markers, biochemical, histopathological, immunohistochemical and electron microscopy study

Effects of Nrf1 in Hypothalamic Paraventricular Nucleus on Regulating the Blood Pressure During Hypertension

Genistein Prevents Nitric Oxide Deficiency-Induced Cardiac Dysfunction and Remodeling in Rats